BACKGROUND: There is evidence that adrenomedullin has autocrine or paracrine activities that oppose cardiac remodelling. However, it remains unclear whether it exerts those local functions in heart failure patients. OBJECTIVE: To investigate the relation between plasma and pericardial fluid concentrations of adrenomedullin and left ventricular haemodynamic variables. DESIGN: Samples of plasma and pericardial fluid were obtained from 50 patients undergoing cardiac surgery. They were classified into two groups: group N (n = 27) with a left ventricular end diastolic volume index (LVEDVI) < or = 90 ml/m(2); and group R (n = 23) with LVEDVI > 90 ml/m(2). Plasma and pericardial fluid concentrations of total adrenomedullin (tAM) and mature adrenomedullin (mAM) were measured and related to the preoperative haemodynamic variables. RESULTS: Pericardial fluid concentrations of mAM were much higher than the plasma concentration in both group N and group R (mean (SEM), 10.6 (1.7) v 3.3 (0.2) fmol/ml, p = 0.0001; and 21.2 (2.8) v 3.9 (0.3) fmol/ml, p < 0.0001, respectively). The ratio mAM/tAM in pericardial fluid was significantly higher than in plasma (0.56 (0.02) v 0.28 (0.02), p < 0.0001). Pericardial fluid concentrations of mAM, but not plasma concentrations, were significantly correlated with LVEDVI, left ventricular end systolic volume index, left ventricular ejection fraction, and left ventricular mass index (r = 0.60, 0.63, -0.54, and 0.47, respectively). CONCLUSIONS: Raised pericardial fluid concentrations of mAM may reflect the actions of adrenomedullin as a local mediator against cardiac remodelling in patients with left ventricular dysfunction.
BACKGROUND: There is evidence that adrenomedullin has autocrine or paracrine activities that oppose cardiac remodelling. However, it remains unclear whether it exerts those local functions in heart failurepatients. OBJECTIVE: To investigate the relation between plasma and pericardial fluid concentrations of adrenomedullin and left ventricular haemodynamic variables. DESIGN: Samples of plasma and pericardial fluid were obtained from 50 patients undergoing cardiac surgery. They were classified into two groups: group N (n = 27) with a left ventricular end diastolic volume index (LVEDVI) < or = 90 ml/m(2); and group R (n = 23) with LVEDVI > 90 ml/m(2). Plasma and pericardial fluid concentrations of total adrenomedullin (tAM) and mature adrenomedullin (mAM) were measured and related to the preoperative haemodynamic variables. RESULTS: Pericardial fluid concentrations of mAM were much higher than the plasma concentration in both group N and group R (mean (SEM), 10.6 (1.7) v 3.3 (0.2) fmol/ml, p = 0.0001; and 21.2 (2.8) v 3.9 (0.3) fmol/ml, p < 0.0001, respectively). The ratio mAM/tAM in pericardial fluid was significantly higher than in plasma (0.56 (0.02) v 0.28 (0.02), p < 0.0001). Pericardial fluid concentrations of mAM, but not plasma concentrations, were significantly correlated with LVEDVI, left ventricular end systolic volume index, left ventricular ejection fraction, and left ventricular mass index (r = 0.60, 0.63, -0.54, and 0.47, respectively). CONCLUSIONS: Raised pericardial fluid concentrations of mAM may reflect the actions of adrenomedullin as a local mediator against cardiac remodelling in patients with left ventricular dysfunction.
Authors: T Sumimoto; T Nishikimi; M Mukai; K Matsuzaki; E Murakami; S Takishita; A Miyata; H Matsuo; K Kangawa Journal: Hypertension Date: 1997-09 Impact factor: 10.190
Authors: K Nishio; Y Akai; Y Murao; N Doi; S Ueda; H Tabuse; S Miyamoto; K Dohi; N Minamino; H Shoji; K Kitamura; K Kangawa; H Matsuo Journal: Crit Care Med Date: 1997-06 Impact factor: 7.598
Authors: T Tanaka; K Hasegawa; M Fujita; S I Tamaki; A Yamazato; Y Kihara; R Nohara; S Sasayama Journal: J Am Coll Cardiol Date: 1998-02 Impact factor: 24.094
Authors: M Fujita; M Ikemoto; M Kishishita; H Otani; R Nohara; T Tanaka; S Tamaki; A Yamazato; S Sasayama Journal: Circulation Date: 1996-08-15 Impact factor: 29.690
Authors: T Tsuruda; J Kato; K Kitamura; K Kuwasako; T Imamura; Y Koiwaya; T Tsuji; K Kangawa; T Eto Journal: Hypertension Date: 1998-01 Impact factor: 10.190
Authors: T Nishikimi; Y Saito; K Kitamura; T Ishimitsu; T Eto; K Kangawa; H Matsuo; T Omae; H Matsuoka Journal: J Am Coll Cardiol Date: 1995-11-15 Impact factor: 24.094
Authors: F Horkay; M Laine; I Szokodi; J Leppäluoto; O Vuolteenaho; H Ruskoaho; A Juhász-Nagy; M Tóth Journal: J Cardiovasc Pharmacol Date: 1995 Impact factor: 3.105
Authors: M Jougasaki; R J Rodeheffer; M M Redfield; K Yamamoto; C M Wei; L J McKinley; J C Burnett Journal: J Clin Invest Date: 1996-05-15 Impact factor: 14.808
Authors: Sarah E Wetzel-Strong; Manyu Li; Scott T Espenschied; Kathleen M Caron Journal: Am J Physiol Regul Integr Comp Physiol Date: 2015-11-18 Impact factor: 3.619
Authors: Suvi M Kuosmanen; Juha Hartikainen; Mikko Hippeläinen; Hannu Kokki; Anna-Liisa Levonen; Pasi Tavi Journal: PLoS One Date: 2015-03-12 Impact factor: 3.240